Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar I Disorder”

358 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 358 results

Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Testing effectiveness (Phase 2)Study completedNCT02363738
What this trial is testing

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Who this might be right for
Bipolar Depression
University Health Network, Toronto 60
Not applicableStudy completedNCT02330068
What this trial is testing

Microbiome of Depression & Treatment Response to Citalopram

Who this might be right for
Major Depressive Disorder, Bipolar I and Bipolar II
Mayo Clinic 34
Large-scale testing (Phase 3)Study completedNCT01986101
What this trial is testing

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Who this might be right for
Bipolar Depression
Sumitomo Pharma Co., Ltd. 525
Large-scale testing (Phase 3)Study completedNCT01059539
What this trial is testing

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Forest Laboratories 403
Not applicableEnded earlyNCT04058249
What this trial is testing

Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder

Who this might be right for
Bipolar Disorder, ManicBipolar Disorder I
Stanford University 1
Post-approval studies (Phase 4)Study completedNCT00182013
What this trial is testing

Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

Who this might be right for
Bipolar Spectrum Disorder
Massachusetts General Hospital 106
Large-scale testing (Phase 3)Study completedNCT00113594
What this trial is testing

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Eli Lilly and Company 100
Not applicableEnrolling By InvitationNCT00762866
What this trial is testing

Psychiatric Genotype/Phenotype Project Repository

Who this might be right for
Depressive Disorder, MajorBipolar DisorderPsychotic Disorders
Vanderbilt University 2,000
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Study completedNCT02600494
What this trial is testing

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 554
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Testing effectiveness (Phase 2)UnknownNCT02630888
What this trial is testing

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients

Who this might be right for
Bipolar Disorder
University of Sao Paulo 44
Large-scale testing (Phase 3)Study completedNCT00081380
What this trial is testing

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
AstraZeneca 710
Large-scale testing (Phase 3)WithdrawnNCT01124877
What this trial is testing

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Early research (Phase 1)Study completedNCT04127058
What this trial is testing

Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia

Who this might be right for
Bipolar I DisorderSchizophrenia
Vanda Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT00238485
What this trial is testing

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Novartis 251
Post-approval studies (Phase 4)Study completedNCT01430455
What this trial is testing

Tranylcypromine Treatment of Bipolar Depression

Who this might be right for
Bipolar Disorder I or II
New York State Psychiatric Institute 7
Post-approval studies (Phase 4)UnknownNCT03881449
What this trial is testing

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

Who this might be right for
SchizophreniaMajor Depressive DisorderBi-Polar Disorder+1 more
Durham VA Medical Center 46
Post-approval studies (Phase 4)Study completedNCT00094549
What this trial is testing

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 500
Load More Results